Welcome to our dedicated page for Becton Dickinson & Co SEC filings (Ticker: BDX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Becton, Dickinson and Company (BD) SEC filings page for ticker BDX provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a New Jersey–incorporated issuer with common stock listed on the New York Stock Exchange, BD files current reports on Form 8-K, annual and quarterly reports, proxy statements and other documents that give investors insight into its financial condition, governance and capital structure.
BD’s recent Form 8-K filings include disclosures on financial results, such as preliminary unaudited revenue and quarterly earnings press releases, as well as corporate events like executive transitions, board appointments and changes in credit facilities. For example, BD has reported the appointment of new directors, the planned transition of its chief financial officer role, and the execution of a third amended and restated revolving credit agreement that provides senior unsecured financing for general corporate purposes. Other 8-K filings describe temporary blackout periods under the BD 401(k) Plan related to a transaction involving Waters Corporation.
Investors can also review BD’s definitive proxy statement on Schedule 14A, which outlines matters for shareholder voting, board composition, executive compensation programs and strategic themes such as the BD2025 and Excellence Unleashed strategies. Debt-related filings, including listings of various series of notes and a Form 25 relating to the removal from listing of 0.034% Notes due 2025, help users understand BD’s capital markets activities. Common stock and several note issues remain registered and listed on the NYSE, as indicated in the filings.
On this page, Stock Titan presents BD’s SEC filings alongside AI-powered summaries that highlight key points from lengthy documents, such as 10-K and 10-Q reports, 8-K event descriptions and proxy materials. Users can quickly identify information about BD’s revolving credit facilities, leverage covenants, executive changes, shareholder meetings and note listings, while still having the option to review the full original filings from EDGAR for detailed analysis.
Becton, Dickinson and Company executive David Shan reported equity transactions in BDX stock. On 11/26/2025, he received 3,504 restricted stock units under the company’s 2004 Employee and Director Equity-Based Compensation Plan and 1,025 shares from vesting of performance-based equity awards, both at a stated price of $0 per share as these are compensation-related grants.
On the same date, 134 shares of common stock were withheld to cover taxes related to these vestings. After these transactions, Shan directly beneficially owned 8,970 shares of Becton Dickinson common stock. He is listed as an Executive Vice President and Chief ISC Officer, and the filing is made for one reporting person.
Becton, Dickinson and Company executive equity activity: Executive Vice President and Chief People Officer Shana Carol Neal reported equity transactions in Becton Dickinson & Co common stock. On 11/26/2025, she acquired 6,727 shares of common stock as restricted stock units granted under the company’s 2004 Employee and Director Equity-Based Compensation Plan, and 3,525 shares received upon vesting of performance-based equity awards, both at a stated price of $0 per share. The filing also reports 2,454 shares withheld to cover taxes related to the vesting of these performance units and previously reported restricted stock units. After these transactions, she directly beneficially owned 21,326 shares of Becton Dickinson common stock.
Becton, Dickinson and Company executive Roland Goette, EVP and President, EMEA, reported routine equity compensation activity. On 11/26/2025, he acquired 1,906 shares of common stock from restricted stock units granted under the company’s 2004 equity-based compensation plan and 1,237 shares received upon vesting of performance-based equity awards, both at a price of $0 as these are compensation grants.
On the same date, 138 shares were disposed of at a stated price of $0 to cover withholding taxes related to the vesting events. After these transactions, Goette directly owned 17,222 shares of common stock and indirectly held 1,559 shares through the Global Share Investment Program as of November 24, 2025.
Becton, Dickinson and Company executive equity transaction: On 11/26/2025, EVP & President, Medical Essential & BioPharm, Michael David Garrison reported multiple equity-related transactions in Becton Dickinson & Co common stock.
He acquired 7,568 shares as restricted stock units awarded under the company’s 2004 Employee and Director Equity-Based Compensation Plan and 3,048 shares received upon vesting of performance-based equity awards, both at a price of $0 per share. In connection with these vestings, 1,769 shares were withheld to cover withholding taxes.
Following these transactions, he beneficially owned 13,734 shares of Becton Dickinson & Co common stock in direct ownership.
Becton Dickinson & Co executive reports equity award activity. Michael Feld, EVP, CRO & President, Life Sciences, reported transactions in Becton Dickinson & Co common stock on 11/26/2025. He acquired 8,829 shares at a price of $0, reflecting the vesting of restricted stock units granted under the company’s 2004 Employee and Director Equity-Based Compensation Plan.
On the same date, 419 shares were disposed of at $0 to cover withholding taxes related to the vesting of previously reported restricted stock units. After these transactions, Feld directly beneficially owned 16,655 shares of Becton Dickinson & Co common stock.
Becton Dickinson & Co. executive vice president and chief financial officer Christopher DelOrefice reported routine equity award activity. On 11/26/2025, he acquired 6,006 shares of common stock at $0 per share, representing shares received upon vesting of performance-based equity awards. On the same date, 4,245 shares were disposed of at $0 per share, reflecting shares withheld to cover tax obligations tied to this vesting and previously granted restricted stock units. After these transactions, DelOrefice directly beneficially owned 22,982 shares of Becton Dickinson common stock.
Becton, Dickinson and Company executive equity transactions
Richard Byrd, EVP & President Interventional of Becton, Dickinson and Company, reported equity transactions dated 11/26/2025. He acquired 6,447 shares of common stock as restricted stock units granted under the company’s 2004 Employee and Director Equity-Based Compensation Plan, and 2,385 shares received upon vesting of performance-based equity awards, both at a stated price of $0 per share, reflecting stock-based compensation rather than open‑market purchases.
To cover withholding taxes related to the vesting of these performance units and previously reported restricted stock units, 1,719 shares were withheld and reported as disposed of at a price of $0 per share. Following these transactions, Byrd directly beneficially owned 13,849 shares of Becton Dickinson common stock.
Becton, Dickinson and Company executive receives stock-based compensation grant
Becton, Dickinson and Company reported that an officer, serving as EVP & President Connected Care, acquired 9,530 shares of common stock on 11/26/2025. The shares are in the form of restricted stock units granted at a price of $0 under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Following this grant, the reporting person beneficially owns 21,751 shares of Becton Dickinson common stock in direct ownership.
Becton Dickinson & Co. reported equity award activity for its Chairman, CEO and President. On 11/26/2025, the executive acquired 22,521 shares of common stock at $0, representing shares received upon vesting of performance-based equity awards. On the same date, 17,421 shares of common stock were disposed at $0, representing shares withheld to cover taxes related to these performance units and previously reported restricted stock units.
The executive’s directly owned common stock after these transactions totaled 105,471 shares. In addition, the executive was granted stock appreciation rights covering 165,581 shares of common stock with a conversion or exercise price of $193.9 per share. These stock appreciation rights become exercisable in four annual installments beginning on 11/26/2026 and expire on 11/26/2035, and are held directly.
Becton, Dickinson and Company and Becton Dickinson Euro Finance S.à r.l. have filed Post-Effective Amendment No. 2 to a Form S-3 shelf registration statement covering up to $10,000,000,000 of securities. The base prospectus allows BD to offer common stock, preferred stock, depositary shares, debt securities, warrants, purchase contracts and units, while Becton Finance may issue debt securities fully and unconditionally guaranteed by BD.
The filing converts the prior automatic shelf to a non-automatic shelf as BD expects to no longer qualify as a well-known seasoned issuer. Specific terms, including pricing and structure of each series, will be set in future prospectus supplements, and BD states that net proceeds, unless otherwise indicated, will be used for general corporate purposes such as working capital, acquisitions, debt retirement and other business opportunities.